BMP2 and pericardial effusion: Taken together, our data demonstrate that BMP2 GT is unsuitable for inducing beneficial effects in adult myocardium after chronic ischemia and that BMP2 transgene induces pericardial effusion and inflammatory responses, which prevent its use in treating chronic CAD.